BALAXI PHARMACEUTICALS LIMITED BALAXI

ताज़ा फ़ाइलिंग

• General30 12 Nov, 20:50 · NSE
  A press release dated November 12, 2026, titled "Balaxi Pharmaceuticals Limited Reports Strong Q2 FY27 Performance; Revenue Grows 45%, EBITDA Surges 338% and PAT Rises 450% YoY".
• General25 12 Nov, 14:07 · NSE
  Progress of the Company's Pharmaceutical Formulation Plant at Jadcherla, Hyderabad.
• Management change70 12 Nov, 14:03 · NSE
  Change in Management
• Board meeting50 12 Nov, 14:01 · NSE
  Outcome of Board Meeting held on November 12, 2026.
• Results73 12 Nov, 13:58 · NSE
  , the financial results for the period ended September 30, 2026.
• General25 11 Nov, 23:10 · NSE
  'RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended October 2026".
• Routine15 7 Oct, 14:36 · NSE
  Certificate under SEBI (Depositories and Participants) Regulations, 2018
• Routine15 7 Oct, 24:15 · NSE
  'RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended September 2026."
• Routine15 6 Oct, 11:33 · NSE
  Newspaper Publication
• Routine15 27 Sept, 17:51 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

प्रकाशन के 15 मिनट बाद दिखाई गई। Pro में रियल-टाइम।